Ítem
Acceso Abierto

The use of insect cells to identify potent and selective inhibitors of the replication of the Dengue and Chikungunya viruses and unravel their molecular mechanism of action

dc.contributor.advisorBello García, Felio Jesús
dc.contributor.advisorNeyts, Johan
dc.creatorSegura Guerrero, Nidya Alexandra
dc.creator.degreeDoctor en Ciencias Biomédicas
dc.date.accessioned2016-04-01T19:45:16Z
dc.date.available2016-04-01T19:45:16Z
dc.date.created2015-12-10
dc.date.issued2015
dc.description.abstractDengue and Chikungunya viruses cause the most important arthropod-borne viral infections for humans. These viruses are predominant in tropical and subtropical regions. In addition, these viruses are predominant in tropical and subtropical regions. Dengue mortality rate is around 1.2 to 3.5% and deaths due to chikungunya fever are around 1 in 1000; however, half of chikungunya-infected patients evolve into a chronic state that can persist for months up to years. There are no antiviral drugs available for DENV and CHIKV treatment and prevention. Moreover, vector control strategies have failed so far. Thus, the development of potent inhibitors for a broad spectrum of RNA viruses is urgently needed. We established and characterized a new embryonic insect cell line from Culex quinquefasciatus mosquito. Also we established the flaviviruses and alphavirus replication, both in C6/36 and Lulo insect cell lines, as well as in Vero cell line. In addition we carried out a reference compound library and reference panel of assays and data for DENV, which provides a benchmark for further studies. During this study, a panel of 9 antiviral molecules, with proven in vitro anti-dengue virus activity and that act at different stages of the DENV life cycle, was selected. Finally, Favipiravir or T-705, was identified as inhibitor in vitro and in vivo of alphaviruses and the mutation K291R in nsP4, which is responsible of the polymerase activity, was found as the mode of action in CHIKV. Interestingly, lysine in motif F1 is also highly conserved in positive-stranded RNA viruses and this might explain the broad spectrum of T-705 antiviral activity.eng
dc.description.sponsorshipColcienciasspa
dc.description.sponsorshipErasmus Mundusspa
dc.description.sponsorshipKU Leuvenspa
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.48713/10336_11891
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/11891
dc.language.isospa
dc.publisherUniversidad del Rosariospa
dc.publisher.departmentFacultad de Ciencias Naturales y Matemáticasspa
dc.publisher.programDoctorado en Ciencias Biomédicasspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto completo)spa
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.spa
dc.source.bibliographicCitationChen, L.H. & Wilson, M.E., 2010. Dengue and chikungunya infections in travelers. Current opinion in infectious diseases, 23(5), pp.438–44. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20581669 [Accessed July 10, 2013].
dc.source.bibliographicCitationEnserik, M., 2006. Massive Outbreak Draws Fresh Attention to Little-Known Virus. Science, 311(February), p.2006.
dc.source.bibliographicCitationManimunda, S.P. et al., 2010. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Transactions of the Royal Society of Tropical Medicine and Hygiene, 104(6), pp.392–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20171708 [Accessed October 4, 2012].
dc.source.bibliographicCitationOrganización Panamericana de la Salud, 2014. Número de casos reportados de chikungunya en países o territorios de las Américas 2013-2014 (por semana),
dc.source.bibliographicCitationPowers, A.M. et al., 2001. Evolutionary Relationships and Systematics of the Alphaviruses. Journal of virology, 75(21), pp.10118–10131.
dc.source.bibliographicCitationSolignat, M. et al., 2009. Replication cycle of chikungunya: A re-emerging arbovirus. Virology, 393(2), pp.183–197.
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.ddcEnfermedades
dc.subject.decsDenguespa
dc.subject.decsVirus Chikungunyaspa
dc.subject.decsControl de Vectoresspa
dc.subject.keywordFavipiravireng
dc.subject.keywordDengueeng
dc.subject.keywordChikungunyaeng
dc.subject.keywordCell cultureeng
dc.subject.keywordMechanism of actioneng
dc.subject.lembCultivo de célulasspa
dc.titleThe use of insect cells to identify potent and selective inhibitors of the replication of the Dengue and Chikungunya viruses and unravel their molecular mechanism of actionspa
dc.typedoctoralThesiseng
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.type.spaTesis de doctoradospa
local.department.reportEscuela de Medicina y Ciencias de la Saludspa
Archivos
Bloque original
Mostrando1 - 3 de 3
Cargando...
Miniatura
Nombre:
PhD thesis Alexandra Segura 2016.pdf
Tamaño:
3.54 MB
Formato:
Adobe Portable Document Format
Descripción:
PhD thesis Segura NA
Cargando...
Miniatura
Nombre:
Delang-Segura et al Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir.pdf
Tamaño:
93.46 KB
Formato:
Adobe Portable Document Format
Descripción:
Resume articulo principal
Cargando...
Miniatura
Nombre:
Segura et al Establishment and characterisation of a new cell line derived from Culex quinquefasciatus.pdf
Tamaño:
109.73 KB
Formato:
Adobe Portable Document Format
Descripción:
Resumen articulo